Effectiveness of orlistat versus diet and exercise for weight gain associated with antidepressant use: A pilot study [4]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 5, 2004, Pages 555-556

  Schwartz, Thomas L ^a   Jindal, Shefali ^a   Simionescu, Mihai ^a   Nihalani, Nikhil ^a   Azhar, Nouman ^a   Tirmazi, Syed ^a   Hussein, Juhi ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOZAPINE; LITHIUM; METFORMIN; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE;

BODY WEIGHT DISORDER; CLINICAL ARTICLE; DEPRESSION; DIARRHEA; DIET; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; EXERCISE; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; PRIORITY JOURNAL; SEROTONIN SYNDROME; WEIGHT GAIN;

ADULT; ANTI-OBESITY AGENTS; ANTIDEPRESSIVE AGENTS; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; DIET, REDUCING; ENZYME INHIBITORS; EXERCISE; FEMALE; HUMANS; LACTONES; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 4644252327     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000138777.71009.61     Document Type: Letter

References (12)

1. Atmaca M, Kuloglu M, Tezcan E, et al. Weight gain and serum leptin levels in patients on lithium treatment. Neuropsychobiology. 2002;46:67-69.
2. Monteleone P, Fabrazzo M, Tortorella A, et al. Pronounced, early increase in circulating leptin predicts a lower weight gain during clozapine treatment. J Clin Psychopharmacol. 2002;22:424-426.
3. Reynolds GP, Zhang ZJ, Zhang X. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet. 2002;359:2086-2087.
4. Ellingrod VL, Miller D, Schultz SK, et al. CYP2D6 polymorphisms and atypical antipsychotic weight gain. Psychiatr Genet. 2002;12:55-58.
5. Fava M. Weight gain and antidepressants. J Clin Psychiatry. 2000;61:37-41.
6. Masand PS, Gupta S. Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatr. 1999;7:69-84.
7. Gokcel A, Gumurdulu Y, Karakose H, et al. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Diabetes Oben Metab. 2002;4:49-55.
8. Gracious BJ, Krysiak TE, Youngstrom EA. Amantadine treatment of psychotropic-induced weight gain in children and adolescents: case series. J Child Adolesc Psychopharmacol. 2002;12:249-257.
9. Lessig MC, Shapira NA, Murphy TK. Topiramate for reversing atypical antipsychotic weight gain. J Am Acad Child Adolesc Psych. 2001;40:1364.
10. Sjostrom L, Rissanen A, Andersen T, et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998;352:167-173.
11. Anghelescu I, Klawe C, Benkert O. Orlistat in the treatment of psychopharmacologically induced weight gain. J Clin Psychopharmacol. 2000;20:716-717.
12. Schwartz TL, Beale M. Psychotropic induced weight gain alleviated with orlistat: a case series. Psychopharmacol Bull. 2003;37(1):5-8.